Ownership

Andrew Reardon - CLO & Secretary at Ligand Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: CLO & Secretary
Stock Symbol: LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Andrew Reardon - trading volume in the past year for Ligand Pharmaceuticals Inc

	Shares	%	Avg Price	Total $
Buys
Sells	-13.5K	100%	$88.09	-$1.19M
Net	-13.5K	-100%		-$1.19M

Holdings reported by Andrew Reardon for Ligand Pharmaceuticals Inc

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	22.5K	$2.24M	$99.60	Sep 23, 2024	Direct
Employee Stock Option (right to buy)	70.9K			Sep 23, 2024	Direct	Common Stock
Non-Qualified Stock Option (right to buy)	62.9K			May 9, 2024	Direct	Common Stock
Non-Qualified Stock Option (right to buy)	61.4K			Aug 28, 2024	Direct	Common Stock

Transactions reported by Andrew Reardon for Ligand Pharmaceuticals Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.